MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

101.05 +0.36 (+0.36%)
Official Closing Price Updated: 7:00 PM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,690,294
Open 100.40
Bid (Size) 101.00 (100)
Ask (Size) 101.45 (100)
Prev. Close 100.69
Today's Range 100.40 - 102.18
52wk Range 99.05 - 139.06
Shares Outstanding 1,750,942,289
Dividend Yield 2.49%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Top Wall Street Forecasters Revamp Abbott Expectations Ahead Of Q1 Earnings ↗
Abbott Laboratories (NYSE: ABT) to report Q1 earnings on April 16, expected EPS of $1.15 and revenue of $11B. Acquired Exact Sciences, stock up 0.4%. 
Via Benzinga
News headline image
Wall Street's Great Rotation: Goldman and JPMorgan Pivot to 'Innovation Supercycle' as Interest Income Peaks
As the sun sets on the era of easy profits from elevated interest rates, the titans of Wall Street are preparing to unveil a new chapter in their growth stories. For the first time in three years, the... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy

Performance

YTD
-18.6%
-18.6%
1 Month
-8.1%
-8.1%
3 Month
-18.7%
-18.7%
6 Month
-24.2%
-24.2%
1 Year
-21.0%
-21.0%

More News

Read More
News headline image
The Era of the Megadeal: Inside the $438 Billion Surge Reshaping Corporate America
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Abbott Laboratories (NYSE:ABT) Stands Out as a Dependable Dividend Stock ↗
Via Chartmill
Abbott Laboratories (NYSE:ABT) Passes the 'Caviar Cruise' Quality Investing Screen ↗
Via Chartmill
News headline image
The Great Consolidation: Q1 2026 M&A Activity Shatters Records Amid $3 Trillion Private Equity Surge
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
This Pharma Dividend Has Been Raised Every Single Year for Over a Decade ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain? ↗
Via MarketBeat
News headline image
Hologic, Inc. (NASDAQ: HOLX): A New Chapter as a Women’s Health Powerhouse
Via Finterra
Topics Artificial Intelligence Retirement World Trade
News headline image
The Decacorn of Performance: Whoop Secures $10.1 Billion Valuation in Landmark Series G Led by TPG
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Robotic Revolution in the Electrophysiology Lab: FDA Clears Stereotaxis Synchrony System
Via MarketMinute
Topics Artificial Intelligence
News headline image
Stereotaxis Secures FDA Clearance for Synchrony™ System, Completing Its Vision for the Robotic "Digital Cockpit"
Via MarketMinute
News headline image
The “New BD”: A Deep-Dive Research Report on Becton, Dickinson and Company (BDX) in 2026
Via Finterra
Topics Artificial Intelligence
News headline image
The Martha Transformation: A Deep Dive into Medtronic’s 2026 Pivot
Via Finterra
Topics Artificial Intelligence Initial Public Offering Product Recall
News headline image
1 Healthcare Stock on Our Watchlist and 2 We Find Risky
Via StockStory
News headline image
Wall Street's Advisory Windfall: Goldman Sachs and JPMorgan Lead the M&A Renaissance
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Best Healthcare Stocks to Buy Right Now for Long-Term Growth ↗
Via The Motley Fool
News headline image
The Great Rebound: US Megadeals Surge 319% as Corporate Consolidation Returns with a Vengeance
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Evolution of a MedTech Giant: A Deep Dive into Becton, Dickinson and Company (BDX)
Via Finterra
Topics Economy Lawsuit Product Recall
News headline image
The Medtronic Transformation: A Deep Dive into the Future of a MedTech Titan
Via Finterra
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Deep Dive: Boston Scientific (BSX) and the New Era of Medical Device Dominance
Via Finterra
Topics Lawsuit Product Recall
News headline image
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks ↗
Via The Motley Fool
Topics ETFs Stocks
News headline image
The Great Divergence: Q1 2026 M&A Hits Record $813.3 Billion Amidst "K-Shaped" Recovery
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics
Via MarketMinute
Topics Supply Chain
News headline image
2 Defensive Healthcare Stocks to Buy Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence Economy

Frequently Asked Questions

Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories is publicly traded.
What exchange does Abbott Laboratories trade on?
Abbott Laboratories trades on the New York Stock Exchange
What is the ticker symbol for Abbott Laboratories?
The ticker symbol for Abbott Laboratories is ABT on the New York Stock Exchange
What is the current price of Abbott Laboratories?
The current price of Abbott Laboratories is 101.05
When was Abbott Laboratories last traded?
The last trade of Abbott Laboratories was at 04/14/26 07:00 PM ET
What is the market capitalization of Abbott Laboratories?
The market capitalization of Abbott Laboratories is 176.93B
How many shares of Abbott Laboratories are outstanding?
Abbott Laboratories has 177B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story